Institutional members access full text with Ovid®

Share this article on:

Use of First-Line Treatment for Neisseria gonorrhoeae After Treatment Guideline Changes

Anschuetz, Greta MPH*; Asbel, Lenore MD*; Salmon, Melinda E. BA*†; Johnson, Caroline C. MD*

Sexually Transmitted Diseases: January 2014 - Volume 41 - Issue 1 - p 64–66
doi: 10.1097/OLQ.0000000000000061
The Real World of STD Prevention

After 2 notices with treatment recommendation changes for Neisseria gonorrhoeae, the Philadelphia Department of Public Health documented medical therapy for 92% (3279/3551) of cases; 3001 (92%) received a recommended therapy. Nonrecommended therapies were documented in 8% of cases. Providers diagnosing 2 or less N. gonorrhoeae cases were more likely to use nonrecommended therapy.

Uptake of recommended dual therapy for Neisseria gonorrhoeae in Philadelphia has been high, with 92% of reported cases receiving a recommended therapy and 8% receiving a nonrecommended therapy.

From the *Division of Disease Control, Philadelphia Department of Public Health, Philadelphia, PA; and †Division of STD Prevention, US. Centers for Disease Control and Prevention, Atlanta, GA

Funding for this analysis was made possible by funding from Comprehensive STD Prevention Systems Projects grant.

The authors have no conflict of interests to report.

Correspondence: Greta Anschuetz, MPH, Philadelphia Department of Public Health, 500 S. Broad St, Philadelphia, PA 19146. E-mail: Greta.Anschuetz@phila.gov.

Received for publication June 10, 2013, and accepted October 15, 2013.

© Copyright 2014 American Sexually Transmitted Diseases Association